There were 3918 patients with human epidermal growth factor receptor 2 (HER2) status in the database of the Cancer Research Center (CRC), among which, 24 male patients and 312 patients with missing DFS and OS information and no encounter after the first visit, were excluded. This evidence concerns the gene ERBB2 and cancer.